FOSAMAX ®, AREDIA ®, ZOMETA ® and ACTONEL ® Bone Death of the Jaw
FOSAMAX ®, AREDIA ®, ZOMETA ® and ACTONEL ® are bisphosphonate medication used for bone loss. It's usage has been linked to the catastrophic condition known as "Dead Jaw" , also known as ONJ - Osteonecrosis of the Jaw or necrosis of the jaw or other bones.
If you or a loved one have taken any of these drugs for osteoporosis,cancer or multiple myeloma & you have experienced complications, contact Bagolie Friedman Injury Lawyers now for a free and confidential consultation.
In the U.S. Package Insert for both Aredia and Zometa, the following information on osteonecrosis had previously been added to the Adverse Reactions section under Post-Marketing Experience.
"Cases of osteonecrosis (primarily involving the jaws) have been reported in patients treated with bisphosphonates. The majority of the reported cases are in cancer patients attendant to a dental procedure. Osteonecrosis of the jaw has multiple well documented risk factors including a diagnosis of cancer, concomitant therapies (e.g., chemotherapy, radiotherapy, corticosteroids) and co-morbid conditions (e.g., anemia, coagulopathies, infection, pre-existing oral disease). Although causality cannot be determined, it is prudent to avoid dental surgery as recovery may be prolonged."
If you have been injured by Fosamax®, Actonel ®, Aredia®, or Zometa®, contact Bagolie Friedman Injury Lawyers now for a free and confidential consultation. Call toll free at 1-866-333-3529 or email at info@bagoliefriedman.com